217 Users Online
Mammalian Cell Expression Kits Market Segmented By cell line type such as Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney Cells, Others
The development of genetic engineering has opened many possibilities of expression for research purposes. Significant advancements in technology have enabled expression of mammalian protein cells in large scale. The mammalian cells are generally used for the production of therapeutic proteins and antibodies.
Mammalian cell expression kits are traditionally seen to be expensive due to the cost associated with specialized media, transfection reagents, consumables, and the professional workforce required. Nowadays mammalian cell expression kits have become the dominant recombinant protein production system for the clinical application. The main challenges observed with using mammalian cell expression kits is the reduced efficiency and levels of the protein expressed.
Increasing research activities and large-scale production of vaccines and antibodies that require kits and reagents are primarily responsible for raising the demand and driving the growth of the global mammalian cell expression kits market.
The growing prevalence of chronic disease globally is further growing the demand of biologics and later contributing in driving the growth of mammalian cell expression kits market. However, the lack of efficient systems for the detection of post-translational modifications is expected to limit the growth of the global mammalian cell expression kits market.
Lack of cost-effective and efficient systems remains a significant hurdle for the growth of the global mammalian cell expression kits market.
|by cell line type||
|by end users||
The global mammalian cell expression kits market is expected to grow with a moderately increasing CAGR due to the increasing adoption and demand for mammalian cell expression kits. Human embryonic kidney cells are mostly used for the transient expression of recombinant proteins.
They have a highly efficient transfection rate which makes them suitable for customized protein production for research use. Mammalian cell expression kits are considered a major advancement in transient expression technology. Based on the end user, the global mammalian cell expression kits market is segmented into biopharmaceutical companies, academic and research institutes, and others.
On the basis of geography, the global mammalian cell expression kits market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China, and the Middle East & Africa. Presently, North America holds a prominent share in the mammalian cell expression kits market followed by Europe.
The major driving factors which have driven the growth of mammalian cell expression kits market in this regions are the involvement of leading players in the development of new products and updating their existing product portfolio in order to enhance their market presence. The competitiveness among the key players in the North America region is expected to drive innovative products in the mammalian cell expression kits market.
The Asia Pacific mammalian cell expression kits market is expected to grow with a very rapid pace due to the emergence of many local players in the Asia Pacific region. Mammalian cell expression kits market in Latin America and the Middle East and Africa region is expected to show sluggish growth over the forecast period. This is majorly due to the lack of efficient systems and expensive kits.
Some of the key players present in the global mammalian cell expression kits market are Thermo Fisher Scientific, Merck KgaA, AG Scientific, Inc, BPS Bioscience, Inc., Promega Corporation and others. The established market players of mammalian cell expression kits are focusing on increasing their market presence in order to increase their market share. The local and small manufacturers in mammalian cell expression kits market are also targeting to gain maximum market in the global mammalian cell expression kits market.